Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,209 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Completed

Phase Ib/II Study of MCS110 in Combination With PDR001 in Patients With Advanced Malignancies

NCT02807844

Conditions
Breast Diseases, Breast Neoplasms, Digestive System Diseases, +31 more
Locations
  • Dana Farber Cancer Center Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • The West Clinic Germantown, Tennessee, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View all 20 locations
View Trial Details
Completed

An Investigational Immuno-therapy Study of BMS-986205 Combined With Nivolumab, Compared to Nivolumab by Itself, in Patients With Advanced Melanoma

NCT03329846

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • Angeles Clinic and Research Institute Los Angeles, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
  • University Of Chicago Chicago, Illinois, United States
View all 63 locations
View Trial Details
Completed

Hepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to Melanoma

NCT00324727

Conditions
Eye Diseases, Eye Neoplasms, Intraocular Melanoma, +21 more
Locations
  • John Wayne Cancer Institute at Saint John's Health Center Santa Monica, California, United States
  • Swedish Medical Center Englewood, Colorado, United States
  • H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States
  • Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States
View Trial Details
Completed

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

NCT02599402

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution Garran, Australian Capital Territory, Australia
  • Local Institution Camperdown, New South Wales, Australia
  • Local Institution Coffs Harbour, New South Wales, Australia
  • Local Institution Gateshead, New South Wales, Australia
View all 111 locations
View Trial Details
Completed

Aldesleukin in Participants With Metastatic Renal Cell Carcinoma or Metastatic Melanoma

NCT00414765

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations
  • USC/Kenneth Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • James Graham Brown Cancer Center Louisville, Kentucky, United States
  • Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States
View Trial Details
Completed

Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations

NCT02296112

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +13 more
Locations
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details

Related conditions